Table 5 Association analysis of apo B with hyperuricaemia (left) and serum urate (right)
NU vs. HU and gout | Vs. urate in NU and HU groups | |||||||
|---|---|---|---|---|---|---|---|---|
Unadjusted OR [95% CI] | P | Adjusted OR [95% CI] | P | Unadjusted β[95% CI] | P | Adjusted β[95% CI] | P | |
Total apo B ( μmol/L) | ||||||||
Europeans | 0.58 [0.24-1.39] | 0.22 | 0.46 [0.15-1.46] | 0.19 | -0.026 [-0.071-0.019] | 0.26 | -0.014 [-0.048-0.020] | 0.41 |
Polynesians | 0.27 [0.10-0.75] | 0.012 | 0.20 [0.04-0.96] | 0.044 | -0.038 [-0.071--0.004] | 0.031 | -0.017 [-0.057-0.023] | 0.40 |
Combined | 0.41 [0.22-0.77] | 0.005 | 0.47 [0.21-1.04] | 0.062 | -0.034 [-0.061--0.007] | 0.013 | -0.020 [-0.045-0.005] | 0.12 |
VLDL apo B (0.1 μmol/L) | ||||||||
Europeans | 8.13 [2.04-32.42] | 0.003 | 4.04 [0.82-19.83] | 0.086 | 0.046 [0.011-0.081] | 0.011 | 0.001 [-0.002-0.004] | 0.48 |
Polynesians | 2.32 [0.89-6.05] | 0.084 | 1.81 [0.51-6.47] | 0.36 | 0.045 [-0.007-0.098] | 0.089 | -0.002 [-0.004-0.0004] | 0.099 |
Combined | 3.80 [1.74-8.33] | 0.001 | 2.50 [1.00-6.26] | 0.050 | 0.046 [0.017-0.075] | 0.002 | -0.001 [-0.003-0.0005] | 0.18 |